MedRx Co. Ltd. (4586) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for MedRx Co. Ltd. (4586:JPX), powered by AI.

Current Price
¥54
Sector
Healthcare
What is the MedRx Co. Ltd. stock price forecast?

MedRx Co. Ltd. is currently trading at ¥54. View real-time AI analysis on Alpha Lenz.

What is MedRx Co. Ltd. insider trading activity?

View the latest insider trading data for MedRx Co. Ltd. on Alpha Lenz.

What is MedRx Co. Ltd.'s P/E ratio?

View MedRx Co. Ltd.'s valuation metrics on Alpha Lenz.

MedRx Co. Ltd.

JPX · 4586
¥54-1(-1.82%)Market closedJPX regular session 09:00–15:00 JST
Ask about MedRx Co. Ltd.'s future dividend policy...
Alpha Chat Insight

MedRx Co. Ltd.'s ROE is -44.4%. Explore profitability and growth together.

Ask for details

Company Overview

MedRx Co. Ltd. is a pharmaceutical company engaged in the development, production, and marketing of innovative medical products. Specializing in drug delivery systems, MedRx Co. Ltd. focuses on transdermal and intradermal methods, enhancing how therapeutics are administered to patients. The company is well-regarded for its commitment to improving drug efficacy and patient experience through pioneering technologies and formulations. By collaborating with healthcare sectors, research institutions, and biotech industries, MedRx Co. Ltd. plays a crucial role in extending the therapeutic options available to providers and their patients. Based in Japan and operating on an international scale, the company continues to make a significant impact on the pharmaceutical and healthcare markets, contributing to advancements in patient care and treatment methodologies.

CEOMr. Yonehiro Matsumura
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees22

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥128,084,000Revenue
0.00Shares Out
22Employees

Margins

99.06%Gross
-745.91%EBITDA
-735.45%Operating
-722.22%Pre-Tax
-731.84%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

29.13%Rev 3Yr
2.16%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-42.29%ROA
-44.44%ROE
-42.50%ROIC

Financial Health

¥1,754,669,000Cash & Cash Equivalents
¥-1,646,126,000Net Debt
5.30%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

MedRx Co. Ltd. (ticker: 4586) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 22 employees.

The current price is 54 with a P/E ratio of -x and P/B of -x.

ROE is -44.44% and operating margin is -735.45%. Annual revenue is $128M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
MedRx Co. Ltd. (4586) Stock Forecast 2026 ¥54 — Price, Financials & Analyst Targets | Alpha Lenz